ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,264Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 50

$370K Total Retail Price of All Prescriptions

Rank: 6 out of 50

285 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alaska
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 285 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 285 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 4,361 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $76 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alaska
LISINOPRIL 275 237 1 1
SIMVASTATIN 237 212 2 3
WARFARIN SODIUM 201 177 3 16
LEVOTHYROXINE SODIUM 200 176 4 2
FUROSEMIDE 147 124 5 5
ZOLPIDEM TARTRATE 128 107 6 11
OMEPRAZOLE 121 97 7 4
HYDROCHLOROTHIAZIDE 116 103 8 14
AMLODIPINE BESYLATE 111 103 9 6
ATORVASTATIN CALCIUM 110 83 10 10
METOPROLOL TARTRATE 106 88 11 17
POTASSIUM CHLORIDE 98 94 12 13
HYDROCODONE-ACETAMINOPHEN 89 78 S3 13 7
OXYCODONE HCL 87 36 S2 14 34
SERTRALINE HCL 85 82 15 20
ATENOLOL 80 77 16 24
METOPROLOL SUCCINATE 78 52 17 8
LOSARTAN POTASSIUM 73 50 18 19
ALLOPURINOL 70 67 19 25
POLYETHYLENE GLYCOL 3350 64 62 20 84
GABAPENTIN 64 62 20 15
LANTUS 57 31 22 66
ROPINIROLE HCL 51 49 23 138
CARBIDOPA-LEVODOPA 51 41 23 47
SPIRIVA 51 51 23 46
TRAZODONE HCL 50 50 26 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.